A critical resource available to Accelerator's portfolio companies is access to the world-class faculty and staff cutting-edge core facilities of the Institute for Systems Biology (ISB). The ISB's faculty and staff have proven to be critical in both the identification and evaluation of potential investment opportunities, followed by creative contributions to the development strategies of Accelerator Companies. Access to ISB's core facilities enables Accelerator Companies to incorporate capital-intensive and expert-operated infrastructure and technologies into their scientific programs without the expensive capital outlays that would be needed to acquire, operate, and maintain these resources themselves.

Additionally, Accelerator’s investors and affiliates have both internal scientific experts as well as extensive networks of scientific consultants. For any technology, therapeutic class or disease category, this network can be tapped for relevant expertise that can help to drive the disciplined and efficient development of Accelerator company technologies.